Skip to content

Mechanical Cardiopulmonary Resuscitation During Treatment of Acute Respiratory Failure Through Extracorporeal Membrane Oxygenation.

Mechanical Cardiopulmonary Resuscitation During Treatment of Acute Respiratory Failure Through Extracorporeal Membrane Oxygenation.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05342363
Enrollment
117
Registered
2022-04-22
Start date
2022-06-01
Completion date
2023-08-01
Last updated
2023-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Resuscitation, Venovenous Extracorporeal Membrane Oxygenation

Brief summary

In-hospital cardiovascular arrest is associated with poor outcome despite prompt treatment and optimal on-site resources. The population of patients treated by venovenous extracorporeal membrane oxygenation (vv-ECMO) due to pulmonary failure is a very challenging group of patients. To date, the frequency, causes and outcome of cardiovascular arrest in these patients have not been studied. We are aiming to conduct a retrospective observational study of all vv-ECMO patients treated at our ARDS centre.

Interventions

None listed

Sponsors

Goethe University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Patients treated with veno-venous extracorporeal membrane oxygenation (vv-ECMO) due to respiratory failure during acute respiratory distress syndrome (ARDS).

Exclusion criteria

Patients treated with veno-arterial extracorporeal membrane oxygenation (va-ECMO)

Design outcomes

Primary

MeasureTime frameDescription
Survival of mechanical cardiovascular resuscitationDuring the intensive care stay ( usually between 2 and 8 weeks)Survival of mechanical cardiovascular resuscitation

Secondary

MeasureTime frameDescription
Incidence of cardiovascular resuscitation iDuring the observation period 2019-2022Incidence of cardiovascular resuscitation in patients treated with venovenous extracorporeal membrane oxygenation.
Complications of resuscitation treatmentsDuring the intensive care stay ( usually between 2 and 8 weeks)Complications of cardiovascular resuscitation in patients treated with venovenous extracorporeal membrane oxygenation

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026